Autopsy report · NCT03008031
Reduced Contrast Administration in Contrast-enhanced Spectral Mammography (CESM)
Cause of deathNo reason given
Life of this trial
- Ran for about 3 years 3 months before it stopped.
- 11 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Maastricht University Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Breast Neoplasm; Contrast-enhanced Spectral Mammography
- Interventions
- CESM with a reduced dose of contrast agent
- Participants
- 11
- Sites
- 1
- Countries
- Netherlands
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.